Taking the right forecasting approach for rare diseases

8th December 2022
Generating accurate forecasts for rare diseases can be challenging, especially when the treatable population is in the hundreds and there is little data to get you from one number to the next.
Read More

Accelerate Your Forecasting Process with J+D’s Proprietary Software Tool: A Case Study

7th April 2022
J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
Read More

What makes a good (and bad) pharmaceutical forecast model

9th November 2022
Forecasting is essential in providing clarity on decision making about the future, and good quality forecasts can prevent decisions being made which could be commercially damaging to organisations.
Read More

Tips for Forecasting First in Class Treatments

9th November 2022
The first step to creating a forecast for a first-in-class treatment is to define your model structure based on the potential source of business.
Read More

Big pharma boosts efficiency and gains a consistent forecasting approach with J+D’s FC365 platform

14th January 2022
J+D were approached by a global pharmaceutical company who needed a new forecasting solution with a robust process management system to give them a solid foundation when forecasting their pipeline assets. 
Read More

J+D helps pioneering biotech launch an efficient, best-practice forecasting process

21st October 2021
The adoption of Onco+ has helped this biotech cut the forecast development pipeline significantly and supported best practice forecasting within their team.
Read More

Master patient flow analysis to predict pharma demand and provide better patient access.

16th June 2022
Key considerations for creating more accurate patient-based product forecasts.
Read More

Expert strategies to overcome the inherent inaccuracy of long range pharma forecasting

27th May 2022
Here we discuss why managing risk & opportunity is more important than accuracy when tackling your long range planning (LRP)
Read More

J+D Introduce the Next Generation of FC365

30th June 2021
J+D, global pharmaceutical forecasting experts are excited to announce the launch of the next generation of FC365, a unique pharmaceutical forecasting platform that will transform the working practices of forecasting teams everywhere.
Read More

Tips for Forecasting Covid-19 Therapies

1st June 2021
Written March 2021. Learn more about our tips for forecasting Covid-19 therapies. Tip 1: It is best to take a patient-based approach...
Read More

Forecasting Considerations for Sizing the Opportunity in a Covid-19 World

1st June 2021
Written March 2021. Learn more about the forecasting considerations for sizing the opportunity in a Covid-19 world. Tip 1: Factor for an increase in undiagnosed patients.
Read More

Tips for Forecasting Therapies in a Covid-19 World

1st June 2021
Written March 2021. Learn more about forecasting therapies in a Covid-19 world. Tip 1: Look at the market from a patient perspective...
Read More